New data further points to a connection between poor sleep and Alzheimer’s disease, according to researchers at Washington University School of Medicine in St. Louis, Missouri.
The FDA-approved insomnia pill known as suvorexant (under the brand Belsomra) was seen to reduce harmful proteins associated with the disease in subjects who took it before bed, the team reported. They added that sleep disturbances can be a major, early warning sign of the neurodegenerative illness.
Although the study was small and only conducted over a two-night span, it shows “proof-of-concept,” said senior author Dr. Brendan Lucey of the university’s sleep center.
“We don’t yet know whether long-term use is effective in staving off cognitive decline, and if it is, at what dose and for whom. Still, these results are very encouraging,” Lucey added.
Read more at https://nypost.com/2023/04/24/this-sleeping-pill-may-be-key-to-battling-alzheimers/
#alzheimer #suvorexant #science #health
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports: https://www.youtube.com/c/nypostsports
Catch the latest news here: https://nypost.com/
Follow The New York Post on:
Twitter – https://twitter.com/nypost
Facebook – https://www.facebook.com/NYPost